Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer

Gynecological Endocrinology

Volumn 22, Issue 4, 2006, Pages 185-189

  Georgopoulos, Neoklis ^a   Adonakis, George ^a   Fotopoulos, Andreas ^a   Koika, Vasiliki ^a   Spinos, Nikitas ^a   Saltamavros, Alexandros ^a   Keramopoulos, Antonios ^b   Koukouras, Dimitrios ^a   Decavalas, George ^a   Kourounis, George ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b IASO   (Greece)

Author keywords

Breast cancer; Endometrial pathology; Estrogen receptor polymorphisms; Estrogen receptor ; Estrogen receptor ; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; TAMOXIFEN;

ADULT; ALUI GENE; ARTICLE; BREAST CANCER; CANCER STAGING; DNA POLYMORPHISM; ENDOMETRIAL DISEASE; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PVUII GENE; RSAI GENE; XBAI GENE;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 33745727239     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600645767     Document Type: Article

References (17)

1. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-285.
2. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004;64:8891-1900.
3. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-537.
4. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-1467.
5. Kedar RP, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 1994;343:1318-1321.
6. Zhang H, McElrath T, Tong W, Pollard JW. The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol 2003;184:129-140.
7. Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA. Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 2004;15:7490-7499.
8. Cai Q, Shu XO, Jin F, Dai Q, Wen W, Cheng JR, Gao YT, Zheng W. Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomark Prev 2003; 12:853-859.
9. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borresen AL. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994;94:665-670.
10. Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen AC, Kindmark A, Landegren U, Fermer ML, Stiger F, et al. Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res 2004;6:R437-R449.
11. Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 1997;21:379-383.
12. Schuit SCE, van Meurs JBJ, Bergink AP, van der Klift M, Fang Y, Leusink G, Hofman A, van Leeuwen JP, Uitterlinden AG, Pols HA. Height in pre- and postmenopausal women is influenced by estrogen receptor α gene polymorphisms. J Clin Endocrinol Metab 2004;89:303-309.
13. Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT. Joint effect of estrogen receptor β sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res 2003;15:7624-7629.
14. Forsti A, Zhao C, Israelsson E, Dahlman-Wright K, Gustafsson JA, Hemminki K. Polymorphisms in the estrogen receptor β gene and risk of breast cancer: no association. Breast Cancer Res Treat 2003;79:409-413.
15. Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999;72:856-864.
16. Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H. Oestrogen receptor-α gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001;16:51-55.
17. Sundarrajan C, Liao WX, Roy AC, Ng SC. Association between estrogen receptor β gene polymorphisms and ovulatory dysfunction in patients with menstrual disorders. J Clin Endocrinol Metab 2001;86:135-139.